Replies to post #14996 on Momenta Pharmaceuticals, Inc. (MNTA)

[tony111]

Well I am just saying that AMPH killed the golden goose by aggressively cutting price to gain market share. A 4B market has become a 400M market with only 2 generics approved is just stunning. In retrospect, Sndz was very generous with its 25% discount when they are the only generic. Cutting price to gain market share is a terrible idea especially when you are the sole generic.